Our present study reveals that TSPYL5 drives p53 cytoplasm localization and that TSPYL5 depletion enhances p53 nuclear translocation and rescues p53 transcriptional activity, suggesting the potential of TSPYL5-targeted strategy in the treatment of NB. The gene discussed is TP53; the disease is neuroblastoma.